Vertex’s CEO was an AI skeptic. But not anymore.

Vertex Pharmaceuticals chief Reshma Kewalramani said AI could reduce the time spent on drug-approval paperwork from months to ...
InfoWorld

Google boosts Vertex AI Agent Builder with new observability and deployment tools

This strengthens Google’s position against rivals such as Microsoft and AWS as enterprises seek faster, more reliable ways to ...
BioSpace

Novartis, Vertex, More Optimizing Shots on Multiple Goals in Lucrative I&I Space

With immunology and inflammation blockbusters like AbbVie’s Skyrizi and Rinvoq reeling in nearly $7 billion combined in the ...
Zacks Investment Research on MSN

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...
StockStory.org on MSN

5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q3 Earnings Call

Vertex Pharmaceuticals’ third quarter was marked by steady double-digit revenue growth, yet the market responded negatively ...